Determinación de niveles plasmáticos e intracelulares de los inhibidores de la transcriptasa inversa análogos a nucleósidos (NRTI) y del análogo a nucleótido tenofovir disoproxil fumarato (TDF) en pacientes tratados con abacavir y/o lamivudina administrados con o sin TDF
Phase 1
- Conditions
- HIV-infected patients
- Registration Number
- EUCTR2004-000948-25-ES
- Lead Sponsor
- Fundació de Lluita Contra la Sida
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 27
Inclusion Criteria
HIV-infected patients >18 years old
Indetectable viral load
HAART receiving treatment during previous three months including lamivudine and/or ABC and TDF, with ritonavir/lopinavir or nevirapine
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Interruption of the theraphy during the study
Concomitant treatment with other medicinal products that should interaction with antirretroviral treatment
Concomitant treatment with other antirretroviral drugs during the study
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method